R&D Systems™ Recombinant Human ERO1L alpha Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Applications: Enzyme Activity

Supplier:  R&D Systems™ 9855EO020

Catalog No. 9855EO020

Description

The Recombinant Human ERO1L alpha Protein is derived from T. ni (baculovirus). The Recombinant Human ERO1L alpha Protein has been validated for the following applications: Enzyme Activity.

Specifications

• Accession Number: Q96HE7
• Gene ID (Entrez): 30001
• Quantity: 20 μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 °C as supplied. 3 months, -20 to -70 °C under sterile conditions after opening.
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.

• For Use With (Application): Enzyme Activity
• Molecular Weight (g/mol): 53 kDa
• Source: Trichoplusia ni,T. ni (baculovirus)-derived human ERO1L alpha protein Glu24-His468,with a C-terminal 6-His tag
• Regulatory Status: RUO
• Specific Reactivity: ERO1L
• Species: Human
• Buffer: Supplied as a 0.2 μm filtered solution in Tris, NaCl and TCEP.